Insulin-like growth factor i and the pathogenesis of delirium: A review of current evidence

Journal of Aging Research

Volumn 2011, Issue , 2011, Pages

  Adamis, Dimitrios ^a,b   Meagher, David ^c,d  

^a UNIVERSITY OF WEST ATTICA   (Greece)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF LIMERICK   (Ireland)

^d UNIVERSITY HOSPITAL LIMERICK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; GROWTH HORMONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; SOMATOMEDIN C; SOMATOMEDIN C DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

AGING; BRAIN FUNCTION; BRAIN INJURY; COGNITIVE DEFECT; DELIRIUM; DISEASE ASSOCIATION; DRUG EFFICACY; ELECTROENCEPHALOGRAM; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; INFLAMMATION; NEUROBIOLOGY; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; RISK ASSESSMENT; WELLBEING;

EID: 84866726221     PISSN: 20902204     EISSN: 20902212     Source Type: Journal    
DOI: 10.4061/2011/951403     Document Type: Review

References (131)

1. American Psychiatric Association, Task Force on DSM-IV, DSM-IV: Diagnostic and Statistical Manual of Mental Disorders 1994 4th Washington, DC, USA American Psychiatric Association
2. Siddiqi N., House A. O., Holmes J. D., Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age and Ageing 2006 35 4 350 364 2-s2.0-33745403310 10.1093/ageing/afl005 (Pubitemid 43941802)
3. Elie M., Rousseau F., Cole M., Primeau F., McCusker J., Bellavance F., Prevalence and detection of delirium in elderly emergency department patients. Canadian Medical Association Journal 2000 163 8 977 981 2-s2.0-0034680289
4. Young L. J., George J., Do guidelines improve the process and outcomes of care in delirium? Age and Ageing 2003 32 5 525 528 2-s2.0-0141484607 10.1093/ageing/afg094 (Pubitemid 37220510)
5. Meagher D., More attention, less confusion: time to lessen the burden of delirium. International Review of Psychiatry 2009 21 1 1 3 2-s2.0-60749096558 10.1080/09540260802675387
6. Trzepacz P., Meagher D., Leonard M., Levenson J., Delirium. Textbook of Psychosomatic Medicine 2010 Washington, DC, USA American Psychiatric Press
7. Gustafson Y., Berggren D., Brannstrom B., Bucht G., Norberg A., Hansson L. I., Winblad B., Acute confusional states in elderly patients treated for femoral neck fracture. Journal of the American Geriatrics Society 1988 36 6 525 530 2-s2.0-0023896124
8. Rockwood K., Acute confusion in elderly medical patients. Journal of the American Geriatrics Society 1989 37 2 150 154 2-s2.0-0024496333 (Pubitemid 19041113)
9. Levkoff S. E., Evans D. A., Liptzin B., Cleary P. D., Lipsitz L. A., Wetle T. T., Reilly C. H., Pilgrim D. M., Schor J., Rowe J., Delirium: the occurrence and persistence of symptoms among elderly hospitalized patients. Archives of Internal Medicine 1992 152 2 334 340 2-s2.0-0026506903 10.1001/archinte.152.2.334
10. Schor J. D., Levkoff S. E., Lipsitz L. A., Reilly C. H., Cleary P. D., Rowe J. W., Evans D. A., Risk factors for delirium in hospitalized elderly. Journal of the American Medical Association 1992 267 6 827 831 2-s2.0-0026505007 10.1001/jama.267.6.827
11. Elie M., Cole M. G., Primeau F. J., Bellavance F., Delirium risk factors in elderly hospitalized patients. Journal of General Internal Medicine 1998 13 3 204 212 2-s2.0-0031932070 10.1046/j.1525-1497.1998.00047.x (Pubitemid 28129001)
12. Hofman A., Rocca W. A., Brayne C., Breteler M. M. B., Clarke M., Cooper B., Copeland J. R.M., Dartigues J. F., Da Silva Droux A., Hagnell O., Heeren T. J., Engedal K., Jonker C., Lindesay J., Lobo A., Mann A. H., Molsa P. K., Morgan K., O'Connor D. W., The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. International Journal of Epidemiology 1991 20 3 736 748
13. Fick D. M., Agostini J. V., Inouye S. K., Delirium superimposed on dementia: a systematic review. Journal of the American Geriatrics Society 2002 50 10 1723 1732 2-s2.0-0036800422 10.1046/j.1532-5415.2002.50468.x (Pubitemid 35192547)
14. Ansaloni L., Catena F., Chattat R., Fortuna D., Franceschi C., Mascitti P., Melotti R. M., Risk factors and incidence of postoperative delirium in elderly patients after elective and emergency surgery. British Journal of Surgery 2010 97 2 273 280 2-s2.0-74549117744 10.1002/bjs.6843
15. Chrispal A., Prasad Mathews K., Surekha V., The clinical profile and association of delirium in geriatric patients with hip fractures in a tertiary care hospital in India. Journal of Association of Physicians of India 2010 58 1 15 19 2-s2.0-73249140195
16. Franco J. G., josefranco11@hotmail.com Valencia C., Bernal C., Ocampo M. V., Trzepacz P. T., De Pablo J., Mejía M. A., Relationship between cognitive status at admission and incident delirium in older medical inpatients. Journal of Neuropsychiatry and Clinical Neurosciences 2010 22 3 329 337 10.1176/appi.neuropsych.22.3.329
17. Rolfson D. B., McElhaney J. E., Jhangri G. S., Rockwood K., Delirium: validity of the confusion assessment method in detecting postoperative delirium in the elderly. International Psychogeriatrics 1999 11 4 431 438 2-s2.0-0033253005 (Pubitemid 30010788)
18. van Rijsbergen M. W. A., m.w.a.vanrijsbergen@uvt.nl Oldenbeuving A. W., Nieuwenhuis-Mark R. E., Nys G. M. S., Las S. G. M., Roks G., de Kort P. L. M., Delirium in acute stroke: a predictor 7 of subsequent cognitive impairment? A two-year follow-up study. Journal of the Neurological Sciences 2011 306 1-2 138 142 10.1016/j.jns.2011.03.024
19. Alagiakrishnan K., Wiens C. A., An approach to drug induced delirium in the elderly. Postgraduate Medical Journal 2004 80 945 388 393 2-s2.0-3242675065 10.1136/pgmj.2003.017236 (Pubitemid 38961859)
20. Clegg A., andrewpaulclegg@yahoo.co.uk Young J. B., Which medications to avoid in people at risk of delirium: a systematic review. Age and Ageing 2011 40 1 23 29 10.1093/ageing/afq140
21. MacLullich A. M. J., Beaglehole A., Hall R. J., Meagher D. J., Delirium and long-term cognitive impairment. International Review of Psychiatry 2009 21 1 30 42 2-s2.0-60749113418 10.1080/09540260802675031
22. Rockwood K., The occurrence and duration of symptoms in elderly patients with delirium. Journals of Gerontology 1993 48 4 M162 M166 2-s2.0-0027314741 (Pubitemid 23199259)
23. McCusker J., Cole M., Dendukuri N., Han L., Belzile E., The course of delirium in older medical inpatients: a prospective study. Journal of General Internal Medicine 2003 18 9 696 704 2-s2.0-0141650563 10.1046/j.1525-1497.2003. 20602.x (Pubitemid 37174761)
24. Adamis D., Treloar A., Martin F. C., Macdonald A. J. D., Recovery and outcome of delirium in elderly medical inpatients. Archives of Gerontology and Geriatrics 2006 43 2 289 298 2-s2.0-33747372983 10.1016/j.archger.2005.11.005 (Pubitemid 44251228)
25. Jackson J. C., Gordon S. M., Hart R. P., Hopkins R. O., Ely E. W., The association between delirium and cognitive decline: a review of the empirical literature. Neuropsychology Review 2004 14 2 87 98 2-s2.0-3543025110 10.1023/B:NERV.0000028080.39602.17 (Pubitemid 39012554)
26. Rudberg M. A., Pompei P., Foreman M. D., Ross R. E., Cassel C. K., The natural history of delirium in older hospitalized patients: a syndrome of heterogeneity. Age and Ageing 1997 26 3 169 174 2-s2.0-0030839995 10.1093/ageing/26.3.169 (Pubitemid 27290383)
27. Macdonald A. J. D., Treloar A., Delirium and dementia; are they distinct? Journal of the American Geriatrics Society 1996 44 8 1001 1002 2-s2.0-0029822316 (Pubitemid 26287164)
28. Fong T. G., Jones R. N., Shi P., Marcantonio E. R., Yap L., Rudolph J. L., Yang F. M., Kiely D. K., Inouye S. K., Delirium accelerates cognitive decline in alzheimer disease. Neurology 2009 72 18 1570 1575 2-s2.0-67649389937 10.1212/WNL.0b013e3181a4129a
29. Meagher D. J., MacLullich A. M. J., Laurila J. V., Defining delirium for the International Classification of Diseases, 11th Revision. Journal of Psychosomatic Research 2008 65 3 207 214 2-s2.0-49149100855 10.1016/j. jpsychores.2008.05.015
30. Adamis D., Treloar A., Martin F. C., Gregson N., Hamilton G., Macdonald A. J. D., APOE and cytokines as biological markers for recovery of prevalent delirium in elderly medical inpatients. International Journal of Geriatric Psychiatry 2007 22 7 688 694 2-s2.0-34247244313 10.1002/gps.1732 (Pubitemid 47180383)
31. de Rooij S. E., van Munster B. C., Korevaar J. C., Levi M., Cytokines and acute phase response in delirium. Journal of Psychosomatic Research 2007 62 5 521 525 2-s2.0-34247352809 10.1016/j.jpsychores.2006.11.013 (Pubitemid 46635470)
32. MacLullich A. M. J., Ferguson K. J., Miller T., de Rooij S. E. J. A., Cunningham C., Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses. Journal of Psychosomatic Research 2008 65 3 229 238 2-s2.0-49149119577 10.1016/j.jpsychores.2008.05.019
33. Alexia C., Fallot G., Lasfer M., Schweizer-Groyer G., Groyer A., An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis. Biochemical Pharmacology 2004 68 6 1003 1015 2-s2.0-4143074965 10.1016/j.bcp.2004.05.029 (Pubitemid 39094263)
34. Lackey B. R., Gray S. L., Henricks D. M., Actions and interactions of the IGF system in Alzheimer's disease: review and hypotheses. Growth Hormone and IGF Research 2000 10 1 1 13 2-s2.0-0034080888 10.1054/ghir.1999.0129 (Pubitemid 30186953)
35. Torres-Aleman I., Toward a comprehensive neurobiology of IGF-I. Developmental Neurobiology 2010 70 5 384 396 2-s2.0-77949741721 10.1002/dneu.20778
36. Velloso C. P., Regulation of muscle mass by growth hormone and IGF-I. British Journal of Pharmacology 2008 154 3 557 568 2-s2.0-44349083554 10.1038/bjp.2008.153 (Pubitemid 351744951)
37. Yang F. M., Inouye S. K., Fearing M. A., Kiely D. K., Marcantonio E. R., Jones R. N., Participation in activity and risk for incident delirium. Journal of the American Geriatrics Society 2008 56 8 1479 1484 2-s2.0-51249114967 10.1111/j.1532-5415.2008.01792.x
38. Venters H. D., Broussard S. R., Zhou J. H., Bluthé R. M., Freund G. G., Johnson R. W., Dantzer R., Kelley K. W., Tumor necrosis factor α and insulin-like growth factor-I in the brain: is the whole greater than the sum of its parts? Journal of Neuroimmunology 2001 119 2 151 165 2-s2.0-0035479284 10.1016/S0165-5728(01)00388-5 (Pubitemid 32918322)
39. D'Ercole J. A., Ye P., O'Kusky J. R., Mutant mouse models of insulin-like growth factor actions in the central nervous system. Neuropeptides 2002 36 2-3 209 220 2-s2.0-0036551775 10.1054/npep.2002.0893
40. O'Keeffe S. T., Lavan J. N., Predicting delirium in elderly patients: development and validation of a risk-stratification model. Age and Ageing 1996 25 4 317 321 2-s2.0-0030016511 10.1093/ageing/25.4.317 (Pubitemid 26245283)
41. Inouye S. K., Charpentier P. A., Precipitating factors for delirium in hospitalized elderly persons: predictive model and interrelationship with baseline vulnerability. Journal of the American Medical Association 1996 275 11 852 857 2-s2.0-0029917496 10.1001/jama.275.11.852 (Pubitemid 26087222)
42. Doré S., Kar S., Quirion R., Insulin-like growth factor I protects and rescues hippocampal neurons against β -amyloid- and human amylin-induced toxicity. Proceedings of the National Academy of Sciences of the United States of America 1997 94 9 4772 4777 2-s2.0-0030902595 10.1073/pnas.94.9.4772 (Pubitemid 27194319)
43. Jenkens P. J., P.J.Jenkins@qmul.ac.uk Bustin S. A., Evidence for a link between IGF-I and cancer. European Journal of Endocrinology 2004 151 supplement 1 S17 S22 10.1530/eje.0.151S017 (Pubitemid 39276342)
44. Meager A., The Molecular Biology of Cytokines 1998 Chichester, UK John Wiley & Sons
45. De Benedetti F., Alonzi T., Moretta A., Lazzaro D., Costa P., Poli V., Martini A., Ciliberto G., Fattori E., Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I: a model for stunted growth in children with chronic inflammation. Journal of Clinical Investigation 1997 99 4 643 650 2-s2.0-0031025204 (Pubitemid 27097665)
46. Lackey B. R., Gray S. L., Henricks D. M., Does the insulin-like growth factor system interact with prostaglandins and proinflammatory cytokines during neurodegeneration? Experimental Biology and Medicine 2000 224 1 20 27 2-s2.0-0034181499 (Pubitemid 30230414)
47. Lang C. H., Hong-Brown L., Frost R. A., Cytokine inhibition of JAK-STAT signaling: a new mechanism of growth hormone resistance. Pediatric Nephrology 2005 20 3 306 312 2-s2.0-14644404961 10.1007/s00467-004-1607-9 (Pubitemid 40309934)
48. Niedernhofer L. J., Garinis G. A., Raams A., Lalai A. S., Robinson A. R., Appeldoorn E., Odijk H., Oostendorp R., Ahmad A., Van Leeuwen W., Theil A. F., Vermeulen W., Van Der Horst G. T. J., Meinecke P., Kleijer W. J., Vijg J., Jaspers N. G. J., Hoeijmakers J. H. J., A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature 2006 444 7122 1038 1043 2-s2.0-33845914051 10.1038/nature05456 (Pubitemid 46018517)
49. Li Y., Xu W., McBurney M. W., Longo V. D., SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons. Cell Metabolism 2008 8 1 38 48 2-s2.0-45549096918 10.1016/j.cmet.2008.05.004 (Pubitemid 351859225)
50. Rudman D., Kutner M. H., Rogers C. M., Impaired growth hormone secretion in the adult population: relation to age and adiposity. Journal of Clinical Investigation 1981 67 5 1361 1369 (Pubitemid 11099350)
51. Clemmons D. R., Van Wyk J. J., Factors controlling blood concentration of somatomedin C. Clinics in Endocrinology and Metabolism 1984 13 1 113 143 2-s2.0-0021359118 (Pubitemid 14141813)
52. Landin-Wilhelmsen K., Wilhelmsen L., Lappas G., Rosen T., Lindstedt G., Lundberg P., Bengtsson B., Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clinical Endocrinology 1994 41 3 351 357 (Pubitemid 24278330)
53. Boonen S., Lesaffre E., Dequeker J., Aerssens J., Nijs J., Pelemans W., Bouillon R., Relationship between baseline insulin-like growth factor-I (IGF-I) and femoral bone density in women aged over 70 years: potential implications for the prevention of age-related bone loss. Journal of the American Geriatrics Society 1996 44 11 1301 1306 2-s2.0-0029854293 (Pubitemid 26374805)
54. Janssen J. A. M. J. L., Stolk R. P., Pols H. A. P., Grobbee D. E., De Jong F. H., Lamberts S. W. J., Serum free IGF-I, total IGF-I, IGFBP-1 and IGFBP-3 levels in an elderly population: relation to age and sex steroid levels. Clinical Endocrinology 1998 48 4 471 478 2-s2.0-0031807915 10.1046/j.1365-2265. 1998.00300.x (Pubitemid 28258820)
55. Juul A., Main K., Blum W. F., Lindholm J., Ranke M. B., Skakkebaek N. E., The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clinical Endocrinology 1994 41 1 85 93 (Pubitemid 24232532)
56. Paolisso G., Ammendola S., Del Buono A., Gambardella A., Riondino M., Tagliamonte M. R., Rizzo M. R., Carella C., Varricchio M., Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function. Journal of Clinical Endocrinology and Metabolism 1997 82 7 2204 2209 2-s2.0-0030753690 10.1210/jc.82.7.2204 (Pubitemid 27287585)
57. Arai Y., Hirose N., Yamamura K., Shimizu K. I., Takayama M., Ebihara Y., Osono Y., Serum insulin-like growth factor-1 in centenarians: implications of IGF-1 as a rapid turnover protein. Journals of Gerontology A 2001 56 2 M79 M82 2-s2.0-0035145361 (Pubitemid 32121421)
58. Martin F. C., Growth hormone, aging and frailty. Reviews in Clinical Gerontology 1999 9 3 207 214 2-s2.0-0032692975 10.1017/S0959259899009326
59. Thompson J. L., Butterfield G. E., Marcus R., Hintz R. L., Van Loan M., Ghiron L., Hoffman A. R., The effects of recombinant human insulin-like growth factor-I and growth hormone on body composition in elderly women. Journal of Clinical Endocrinology and Metabolism 1995 80 6 1845 1852 2-s2.0-0029064540
60. Copeland K. C., Colletti R. B., Devlin J. T., McAuliffe T. L., The relationship between insulin-like growth factor-I, adiposity, and aging. Metabolism 1990 39 6 584 587 2-s2.0-0025347581 10.1016/0026-0495(90)90022-5 (Pubitemid 20184526)
61. Harris T. B., Kiel D., Roubenoff R., Langlois J., Hannan M., Havlik R., Wilson P., Association of insulin-like growth factor-I with body composition, weight history, and past health behaviors in the very old: the Framingham Heart Study. Journal of the American Geriatrics Society 1997 45 2 133 139 2-s2.0-0031021864 (Pubitemid 27066520)
62. Cappola A. R., Bandeen-Roche K., Wand G. S., Volpato S., Fried L. P., Association of IGF-I levels with muscle strength and mobility in older women. Journal of Clinical Endocrinology and Metabolism 2001 86 9 4139 4146 2-s2.0-0034853487 10.1210/jc.86.9.4139 (Pubitemid 32848526)
63. Cappola A. R., Xue Q. L., Ferrucci L., Guralnik J. M., Volpato S., Fried L. P., Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. Journal of Clinical Endocrinology and Metabolism 2003 88 5 2019 2025 2-s2.0-0038369150 10.1210/jc.2002-021694 (Pubitemid 36549871)
64. Roubenoff R., Parise H., Payette H. A., Abad L. W., D'Agostino R., Jacques P. F., Wilson P. W. F., Dinarello C. A., Harris T. B., Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. American Journal of Medicine 2003 115 6 429 435 2-s2.0-0141892842 10.1016/j.amjmed.2003.05.001 (Pubitemid 37237554)
65. Andreassen M., Raymond I., Kistorp C., Hildebrandt P., Eaber J., Kristensen L. O., IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population. European Journal of Endocrinology 2009 160 1 25 31 2-s2.0-58249090529 10.1530/EJE-08-0452
66. Laughlin G. A., Barrett-Connor E., Criqui M. H., Kritz-Silverstein D., The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo study. Journal of Clinical Endocrinology and Metabolism 2004 89 1 114 120 2-s2.0-0842291511 10.1210/jc.2003-030967 (Pubitemid 38183869)
67. Saydah S., Graubard B., Ballard-Barbash R., Berrigan D., Insulin-like growth factors and subsequent risk of mortality in the United States. American Journal of Epidemiology 2007 166 5 518 526 2-s2.0-34548015443 10.1093/aje/kwm124 (Pubitemid 47283642)
68. Woods K. A., Camacho-Hübner C., Savage M. O., Clark A. J. L., Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. New England Journal of Medicine 1996 335 18 1363 1367 2-s2.0-0029805072 10.1056/NEJM199610313351805 (Pubitemid 26360455)
69. Cheng C. M., Reinhardt R. R., Lee W. H., Joncas G., Patel S. C., Bondy C. A., Insulin-like growth factor 1 regulates developing brain glucose metabolism. Proceedings of the National Academy of Sciences of the United States of America 2000 97 18 10236 10241 2-s2.0-0034730180
70. Beck K. D., Powell-Braxton L., Widmer H. R., Valverde J., Hefti F., Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron 1995 14 4 717 730 2-s2.0-0028941681
71. Deijen J. B., De Boer H., Van Der Veen E. A., Cognitive changes during growth hormone replacement in adult men. Psychoneuroendocrinology 1998 23 1 45 55 2-s2.0-0031748753 10.1016/S0306-4530(97)00092-9 (Pubitemid 28252966)
72. Papadakis M. A., Grady D., Black D., Tierney M. J., Gooding G. A. W., Schambelan M., Grunfeld C., Growth hormone replacement in healthy older men improves body composition but not functional ability. Annals of Internal Medicine 1996 124 8 708 716 2-s2.0-0029993686 (Pubitemid 26117919)
73. Aleman A., De Vries W. R., De Haan E. H. F., Verhaar H. J. J., Samson M. M., Koppeschaar H. P. F., Age-sensitive cognitive function, growth hormone and insulin-like growth factor 1 plasma levels in healthy older men. Neuropsychobiology 2000 41 2 73 78 2-s2.0-0033979799 (Pubitemid 30058127)
74. Aleman A., Verhaar H. J. J., De Haan E. H. F., De Vries W. R., Samson M. M., Drent M. L., Van Der Veen E. A., Koppeschaar H. P. F., Insulin-like growth factor-I and cognitive function in healthy older men. Journal of Clinical Endocrinology and Metabolism 1999 84 2 471 475 2-s2.0-0033010160 10.1210/jc.84.2.471 (Pubitemid 29075671)
75. Mustafa A., Lannfelt L., Lilius L., Islam A., Winblad B., Adem A., Decreased plasma insulin-like growth factor-I level in familial Alzheimer's disease patients carrying the Swedish APP 670/671 mutation. Dementia and Geriatric Cognitive Disorders 1999 10 6 446 451 2-s2.0-0032712557 10.1159/000017188 (Pubitemid 29512010)
76. Murialdo G., Barreca A., Nobili F., Rollero A., Timossi G., Gianelli M. V., Copello F., Rodriguez G., Polleri A., Relationships between cortisol, dehydroepiandrosterone sulphate and insulin-like growth factor-I system in dementia. Journal of Endocrinological Investigation 2001 24 3 139 146 2-s2.0-0035071725 (Pubitemid 32293635)
77. Sara V. R., Hall K., Enzell K., Somatomedins in aging and dementia disorders of the Alzheimer type. Neurobiology of Aging 1982 3 2 117 120 10.1016/0197-4580(82)90006-9 (Pubitemid 13198768)
78. Tham A., Nordberg A., Grissom F. E., Carlsson-Skwirut C., Viitanen M., Sara V. R., Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type. Journal of Neural Transmission Parkinson's Disease and Dementia Section 1993 5 3 165 176 2-s2.0-0027170501 (Pubitemid 23227810)
79. Nasmanl B., Olsson T., Seckl J. R., Abnormalities in adrenal androgens, but not of glucocorticoids, in early Alzheimer's disease. Psychoneuroendocrinology 1995 20 1 83 94 10.1016/0306-4530(94)E0044-A (Pubitemid 24325672)
80. Carro E., Trejo J. L., Gomez-Isla T., LeRoith D., Torres-Aleman I., Serum insulin-like growth factor I regulates brain amyloid- β levels. Nature Medicine 2002 8 12 1390 1397 2-s2.0-0036917631 10.1038/nm793 (Pubitemid 36019424)
81. Zhao W. Q., Lacor P. N., Chen H., Lambert M. P., Quon M. J., Krafft G. A., Klein W. L., Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric A β Journal of Biological Chemistry 2009 284 28 18742 18753 2-s2.0-67650544970 10.1074/jbc.M109.011015
82. Sharma S., Prasanthi J., Schommer E., Feist G., Ghribi O., Hypercholesterolemia-induced A β accumulation in rabbit brain is associated with alteration in IGF-1 signaling. Neurobiology of Disease 2008 32 3 426 432 2-s2.0-56349160982 10.1016/j.nbd.2008.08.002
83. Kar S., Seto D., Doré S., Hanisch U. K., Quirion R., Insulin-like growth factors-I and -II differentially regulate endogenous acetylcholine release from the rat hippocampal formation. Proceedings of the National Academy of Sciences of the United States of America 1997 94 25 14054 14059 2-s2.0-0031459912 10.1073/pnas.94.25.14054 (Pubitemid 28009708)
84. Åberg M. A. I., Åberg N. D., Hedbäcker H., Oscarsson J., Eriksson P. S., Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. Journal of Neuroscience 2000 20 8 2896 2903 2-s2.0-0034656167 (Pubitemid 30220315)
85. Åberg M. A. I., Åberg N. D., Palmer T. D., Alborn A. M., Carlsson-Skwirut C., Bang P., Rosengren L. E., Olsson T., Gage F. H., Eriksson P. S., IGF-I has a direct proliferative effect in adult hippocampal progenitor cells. Molecular and Cellular Neuroscience 2003 24 1 23 40 2-s2.0-10744230450 10.1016/S1044-7431(03)00082-4 (Pubitemid 37194531)
86. Doré S., Bastianetto S., Kar S., Quirion R., Protective and rescuing abilities of IGF-I and some putative free radical scavengers against β -amyloid-inducing toxicity in neurons. Annals of the New York Academy of Sciences 1999 890 356 364 2-s2.0-0033450892 (Pubitemid 30040398)
87. Gasparini L., Xu H., Potential roles of insulin and IGF-1 in Alzheimer's disease. Trends in Neurosciences 2003 26 8 404 406 2-s2.0-0142026832 10.1016/S0166-2236(03)00163-2 (Pubitemid 37288973)
88. Giovannucci E., Nutrition, insulin, insulin-like growth factors and cancer. Hormone and Metabolic Research 2003 35 11-12 694 704 2-s2.0-0346725867 10.1055/s-2004-814147 (Pubitemid 38058173)
89. Zawada W. M., Kirschman D. L., Cohen J. J., Heidenreich K. A., Freed C. R., Growth factors rescue embryonic dopamine neurons from programmed cell death. Experimental Neurology 1996 140 1 60 67 2-s2.0-0030198581 10.1006/exnr.1996. 0115 (Pubitemid 26266594)
90. Zawada W. M., Zastrow D. J., Clarkson E. D., Adams F. S., Bell K. P., Freed C. R., Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Research 1998 786 1-2 96 103 2-s2.0-0032498835 10.1016/S0006-8993(97)01408-X (Pubitemid 28191718)
91. Guan J., Krishnamurthi R., Waldvogel H. J., Faull R. L. M., Clark R., Gluckman P., N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats. Brain Research 2000 859 2 286 292 2-s2.0-0034708539 10.1016/S0006-8993(00)01988-0 (Pubitemid 30136100)
92. Krishnamurthi R., Stott S., Maingay M., Faull R. L. M., McCarthy D., Gluckman P., Guan J., N-terminal tripeptide of IGF-I improves functional deficits after 6-OHDA lesion in rats. NeuroReport 2004 15 10 1601 1604 2-s2.0-3242745832 10.1097/01.wnr.0000127461.15985.07 (Pubitemid 38971179)
93. Trzepacz P. T., The neuropathogenesis of delirium: a need to focus our research. Psychosomatics 1994 35 4 374 391 2-s2.0-0028236953 (Pubitemid 24206400)
94. Trzepacz P. T., Update on the neuropathogenesis of delirium. Dementia and Geriatric Cognitive Disorders 1999 10 5 330 334 2-s2.0-0032811640 10.1159/000017164 (Pubitemid 29403589)
95. Murray C., Sanderson D. J., Barkus C., Deacon R. M. J., Rawlins J. N. P., Bannerman D. M., Cunningham C., Systemic inflammation induces acute working memory deficits in the primed brain: relevance for delirium. Neurobiology of Aging. In press 2-s2.0-77951957277 10.1016/j.neurobiolaging.2010.04.002
96. Wilson K., Broadhurst C., Diver M., Jackson M., Mottram P., Plasma insulin growth factor-1 and incident delirium in older people. International Journal of Geriatric Psychiatry 2005 20 2 154 159 2-s2.0-14044270746 10.1002/gps.1265 (Pubitemid 40277894)
97. Lemstra A. W., Kalisvaart K. J., Vreeswijk R., van Gool W. A., Eikelenboom P., Pre-operative inflammatory markers and the risk of postoperative delirium in elderly patients. International Journal of Geriatric Psychiatry 2008 23 9 943 948 2-s2.0-52649128411 10.1002/gps.2015
98. Adamis D., Lunn M., Martin F. C., Treloar A., Gregson N., Hamilton G., Macdonald A. J. D., Cytokines and IGF-I in delirious and non-delirious acutely ill older medical inpatients. Age and Ageing 2009 38 3 326 332 2-s2.0-65449158857 10.1093/ageing/afp014
99. Morandi A., Gunther M. L., Pandharipande P. P., Jackson J. C., Thompson J. L., Shintani A. K., Ely E. W., Girard T. D., Insulin-like growth factor-1 and delirium in critically ill mechanically ventilated patients: a preliminary investigation. International Psychogeriatrics. In press 10.1017/ S1041610210002486
100. Charriaut-Marlangue C., Ben-Ari Y., A cautionary note on the use of the TUNEL stain to determine apoptosis. NeuroReport 1995 7 1 61 64 2-s2.0-0029549426 (Pubitemid 26077201)
101. Gluckman P. D., Guan J., Williams C., Scheepens A., Zhang R., Bennet L., Gunn A., Asphyxial brain injury-the role of the IGF system. Molecular and Cellular Endocrinology 1998 140 1-2 95 99 2-s2.0-0032565742 10.1016/S0303- 7207(98)00035-5 (Pubitemid 28375218)
102. Filho C. D. M., Holzenberger M., Clemmons D., Robinson I. C. A. F., Christen Y., IGF receptors in the adult brain. IGFs: Local Repair and Survival Factors Throughout Life Span 2010 London, UK Springer 125 142
103. Peruzzi F., Prisco M., Dews M., Salomoni P., Grassilli E., Romano G., Calabretta B., Baserga R., Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Molecular and Cellular Biology 1999 19 10 7203 7215 2-s2.0-0032827420 (Pubitemid 29441900)
104. Párrizas M., LeRoith D., Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of the bcl-xL gene product. Endocrinology 1997 138 3 1355 1358 2-s2.0-0031047044 10.1210/en.138.3.1355 (Pubitemid 27089798)
105. Matheny R. W., Adamo M. L., PI3K p110 alpha and p110 beta have differential effects on Akt activation and protection against oxidative stress-induced apoptosis in myoblasts. Cell Death and Differentiation 2010 17 4 677 688 2-s2.0-77949540081 10.1038/cdd.2009.150
106. Carro E., Trejo J. L., Fernandez S., Fernandez A. M., Torres-Aleman I., Nyberg F., Insulin-like growth factor-I and neuroprotection. The Somatotrophic Axis in Brain Function 2006 London, UK Elsevier Academic Press
107. Yirmiya R., razyirmiya@huji.ac.il Goshen I., Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain, Behavior, and Immunity 2011 25 2 181 213 10.1016/j.bbi.2010.10.015
108. Saatman K. E., Contreras P. C., Smith D. H., Raghupathi R., McDermott K. L., Fernandez S. C., Sanderson K. L., Voddi M., McIntosh T. K., Insulin-like growth factor-1 (IGF-1) improves both neurological motor and cognitive outcome following experimental brain injury. Experimental Neurology 1997 147 2 418 427 2-s2.0-0031257758 10.1006/exnr.1997.6629 (Pubitemid 27497303)
109. Mathews L. S., Norstedt G., Palmiter R. D., Regulation of insulin-like growth factor I gene expression by growth hormone. Proceedings of the National Academy of Sciences of the United States of America 1986 83 24 9343 9347 2-s2.0-0006789567 (Pubitemid 17223357)
110. Hynes M. A., Van Wijk J. J., Brooks P. J., D'Ercole A. J., Jansen M., Lund P. K., Growth hormone dependence of somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II messenger ribonucleic acids. Molecular Endocrinology 1987 1 3 233 242 2-s2.0-0023639511 (Pubitemid 17166942)
111. Lupu F., Terwilliger J. D., Lee K., Segre G. V., Efstratiadis A., Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Developmental Biology 2001 229 1 141 162 2-s2.0-0035175162 10.1006/dbio.2000. 9975 (Pubitemid 32061720)
112. Khorram O., Use of growth hormone and growth hormone secretagogues in aging: help or harm. Clinical Obstetrics and Gynecology 2001 44 4 893 901 2-s2.0-0035202408 10.1097/00003081-200112000-00026 (Pubitemid 33115835)
113. Yeo A. L., Levy D., Martin F. C., Sönksen P., Sturgess I., Wheeler M. M., Young A., Frailty and the biochemical effects of recombinant human growth hormone in women after surgery for hip fracture. Growth Hormone and IGF Research 2003 13 6 361 370 2-s2.0-0344974069 10.1016/j.ghir.2003.08.001 (Pubitemid 37493328)
114. Pearson A., De Vries A., Middleton S. D., Gillies F., White T. O., Armstrong I. R., Andrew R., Seckl J. R., MacLullich A. M., Cerebrospinal fluid cortisol levels are higher in patients with delirium versus controls. BMC Research Notes 2010 3 2-s2.0-77949533088 10.1186/1756-0500-3-33 33
115. Adamo M., Werner H., Farnsworth W., Roberts C. T., Raizada M., LeRoith D., Dexamethasone reduces steady state insulin-like growth factor I messenger ribonucleic acid levels in rat neuronal and glial cells in primary culture. Endocrinology 1988 123 5 2565 2570 2-s2.0-0023812458
116. Lowe W. L. Jr., Meyer T., Karpen C. W., Lorentzen L. R., Regulation of insulin-like growth factor I production in rat C6 glioma cells: possible role as an autocrine/paracrine growth factor. Endocrinology 1992 130 5 2683 2691 2-s2.0-0026772696 10.1210/en.130.5.2683
117. Chan C. B., Tse M. C., Cheng C. H. K., Nyberg F., Regulation and mechanism of growth hormone and insulin-like growth factor-I biosynthesis and secretion. The Somatotrophic Axis in Brain Function 2006 London, UK Elsevier Academic Press 7 23
118. Broadhurst C., Wilson K., Immunology of delirium: new opportunities for treatment and research. British Journal of Psychiatry 2001 179 288 289 2-s2.0-0034771358 10.1192/bjp.179.4.288 (Pubitemid 32996036)
119. Nozaki O., Takagi C., Takaoka K., Takata T., Yoshida M., Psychiatric manifestations accompanying interferon therapy for patients with chronic hepatitis C: an overview of cases in Japan. Psychiatry and Clinical Neurosciences 1997 51 4 175 180 2-s2.0-0030811617 (Pubitemid 27362546)
120. Auernhammer C. J., Strasburger C. J., Effects of growth hormone and insulin-like growth factor I on the immune system. European Journal of Endocrinology 1995 133 6 635 645 2-s2.0-0029619403 (Pubitemid 26022220)
121. Hwa V., Little B., Kofoed E. M., Rosenfeld R. G., Transcriptional regulation of insulin-like growth factor-I by interferon-gamma requires STAT-5b. Journal of Biological Chemistry 2004 279 4 2728 2736 2-s2.0-1642535433 10.1074/jbc.M310495200 (Pubitemid 38114262)
122. Adamis D., Martin F. C., Treloar A., Macdonald A. J. D., Capacity, consent, and selection bias in a study of delirium. Journal of Medical Ethics 2005 31 3 137 143 2-s2.0-12144277192 10.1136/jme.2002.000919 (Pubitemid 40378683)
123. Auerswald K. B., Charpentier P. A., Inouye S. K., The informed consent process in older patients who developed delirium: a clinical epidemiologic study. American Journal of Medicine 1997 103 5 410 418 2-s2.0-0030659079 10.1016/S0002-9343(97)00152-6 (Pubitemid 27506248)
124. Francis J., A half-century of delirium research: time to close the gap. Journal of the American Geriatrics Society 1995 43 5 585 586 2-s2.0-0029301649
125. Adamis D., Treloar A., Martin F. C., Macdonald A. J. D., Ethical research in delirium: arguments for including decisionally incapacitated subjects. Science and Engineering Ethics 2010 16 1 169 174 2-s2.0-77949277642 10.1007/s11948-009-9120-y
126. Guler H. P., Zapf J., Schmid C., Froesch E. R., Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinologica 1989 121 6 753 758 2-s2.0-0024791002 (Pubitemid 20029527)
127. Barkan A. L., Defining normalcy of the somatotropic axis: an attainable goal? Pituitary 2007 10 2 135 139 2-s2.0-34249880522 10.1007/s11102-007-0029-7 (Pubitemid 46863728)
128. Koponen H. J., Leinonen E., Lepola U., Riekkinen P. J., A long-term follow-up study of cerebrospinal fluid somatostatin in delirium. Acta Psychiatrica Scandinavica 1994 89 5 329 334 2-s2.0-0028242814 (Pubitemid 24157954)
129. Ross R., Miell J., Freeman E., Jones J., Matthews D., Preece M., Buchanan C., Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I. Clinical Endocrinology 1991 35 1 47 54 2-s2.0-0025865786
130. Cohen P., Insulin-like growth factor binding protein-3: insulin-like growth factor independence comes of age. Endocrinology 2006 147 5 2109 2111 2-s2.0-33645885053 10.1210/en.2006-0195
131. Kaplan R. C., McGinn A. P., Pollak M. N., Kuller L., Strickler H. D., Rohan T. E., Xue X., Kritchevsky S. B., Newman A. B., Psaty B. M., Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults. Journal of the American Geriatrics Society 2008 56 4 652 660 2-s2.0-41549163949 10.1111/j.1532-5415.2007.01637.x (Pubitemid 351473531)